Lower CYP2C9 activity in Turkish patients with Beh double dagger et's disease compared to healthy subjects: a down-regulation due to inflammation?

Goktas M. T., Hatta F., KARACA O., KALKISIM S., KILIC L., AKDOĞAN A., ...More

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol.71, no.10, pp.1223-1228, 2015 (SCI-Expanded) identifier identifier identifier


Background We previously reported on a Swedish patient with Beh double dagger et's disease (BD) who was an ultra-rapid metaboliser of drugs catalysed by CYP2C9. Was this extreme metabolism caused by the disease?